Search

everythinglearnresearchcommunity

for

Search:↓

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Early-onset male baldness is significantly linked to metabolic syndrome, suggesting those with early baldness should consider preventive treatment to reduce risk.

Many people experience hair loss after weight loss surgery, especially younger women, and it's linked to lower levels of zinc, folic acid, and ferritin.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

The document concludes that there are multiple ways to create PCOS in animals for research, which helps understand and treat the condition.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

People with androgenetic alopecia (hair loss) may have a higher risk of developing metabolic syndrome.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Hair loss may indicate a higher risk of heart disease and other health issues related to metabolism.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

People with early hair loss may have higher insulin levels and a greater chance of developing metabolic syndrome.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Premature hair greying may indicate a higher risk of metabolic problems.

Severe hair loss links to metabolic issues in older men with psoriasis.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

The study found that in Eclipta prostrata roots, coumestans come from acetate and shikimate pathways, and phenylpropanoid is made only through the shikimate pathway.

Finasteride and dutasteride may cause metabolic issues like liver disease and diabetes.

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

Metabolic syndrome's individual issues are real and need treatment to reduce diabetes and heart disease risks.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.